Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Macrophages isolated from regressing Moloney sarcomas are more cytotoxic than those recovered from progressing sarcomas

Abstract

THERE is increasing evidence that many tumours contain appreciable numbers of macrophages1–3, and that these inflammatory cells can be cytotoxic for various neoplastic cells in vitro4,5. Thus at first it seems paradoxical that many tumours are progressive and lethal in spite of a high content of macrophages. But to kill a malignant cell, these inflammatory cells must be brought to an ill-defined state of ‘activation’6,7. It is therefore conceivable that the macrophages in progressing tumours are less activated, and thus less cytotoxic, than those in spontaneously regressing neoplasms. To test this hypothesis we isolated macrophages from either regressing or progressing Moloney sarcomas and tested them in vitro for their capacity to release chromium-51 (51Cr) from prelabelled target cells. The former were usually significantly more cytotoxic than the latter.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Evans, R. Transplantation 14, 468–473 (1972).

    Google Scholar 

  2. Wood, G. W., Gillespie, G. Y. & Barth, R. F. J. Immun. 114, 950–957 (1975).

    CAS  PubMed  Google Scholar 

  3. Russell, S. W., Gillespie, G. Y., Hansen, C. B. & Cochrane, C. G. Int. J. Cancer 18, 331–338 (1976).

    Article  CAS  Google Scholar 

  4. Evans, R. Ann. N. Y. Acad. Sci. 256, 275–287 (1975).

    Article  ADS  CAS  Google Scholar 

  5. Haskill, J. S., Proctor, J. W. & Yamamura, Y. J. natn. Cancer Inst. 54, 387–393 (1975).

    CAS  Google Scholar 

  6. Fidler, I. J. J. natn. Cancer Inst. 55, 1159–1163 (1975).

    Article  CAS  Google Scholar 

  7. Alexander, P. & Evans, R. Nature new Biol. 232, 76–78 (1971).

    Article  CAS  Google Scholar 

  8. Russell, S. W. & Cochrane, C. G. Int. J. Cancer 13, 54–63 (1974).

    Article  CAS  Google Scholar 

  9. Russell, S. W., Francke, U., Buettner, L. & Cochrane, C. G. J. natn. Cancer Inst. 53, 801–806 (1974).

    Article  CAS  Google Scholar 

  10. Fefer, A., McCoy, J. L., Perk, K. & Glynn, J. P. Cancer Res. 28, 1577–1585 (1968).

    CAS  PubMed  Google Scholar 

  11. Russell, S. W., Doe, W. F., Hoskins, R. G. & Cochrane, C. G. Int. J. Cancer 18, 322–330 (1976).

    Article  CAS  Google Scholar 

  12. Russell, S. W., Gillespie, G. Y. & McIntosh, A. T. J. Immun. 118, 1574–1579 (1977).

    CAS  PubMed  Google Scholar 

  13. Gillespie, G. Y., Hansen, C. B., Hoskins, R. G. & Russell, S. W. J. Immun. (in the press).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

RUSSELL, S., MCINTOSH, A. Macrophages isolated from regressing Moloney sarcomas are more cytotoxic than those recovered from progressing sarcomas. Nature 268, 69–71 (1977). https://doi.org/10.1038/268069a0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/268069a0

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing